SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-183372
Filing Date
2023-07-07
Accepted
2023-07-07 08:39:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13D d500963dsc13d.htm SC 13D 51124
2 EX-1.01 d500963dex101.htm EX-1.01 602050
3 EX-1.02 d500963dex102.htm EX-1.02 54140
4 EX-1.03 d500963dex103.htm EX-1.03 83087
  Complete submission text file 0001193125-23-183372.txt   791919
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Subject) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91961 | Film No.: 231075314
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1281 WIN HENTSCHEL BOULEVARD SUITE 1300 WEST LAFAYETTE IN 47906
Business Address 1281 WIN HENTSCHEL BOULEVARD SUITE 1300 WEST LAFAYETTE IN 47906 6502384942
MorphImmune Inc. (Filed by) CIK: 0001911732 (see all company filings)

IRS No.: 844649553 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D